approved supplier to terumo
NAMSA is an approved supplier of biocompatibility testing, preclinical and clinical services. We work closely with the Terumo BCT lab and clinical teams on a variety of projects including:
|
|
terumo has negotiated preferred pricing with NAMSA through 2024:
x%discount on lab services |
x%discount on Consulting services |
namsa offers a full suite of research and compliance services…
CLINICAL RESEARCH
|
MARKET RESEARCH
|
QA/REGULATORY
|
TESTING
|
…and we have deep expertise in the cardiovascular segment, including blood collection devices
Learn more about NAMSA’s deep expertise in cardiovascular and peripheral vascular segments
500
Customized Preclinical Studies
300
Cardiovascular Projects Per Year
7655
Trial Subjects
560
Trial Sites Managed
we have 200+ subject matter experts ready to serve terumo bct
NAMSA works exclusively with medical device manufacturers and has a deep pool of preclinical, clinical and compliance experts based in the United States and Europe. Whether you need help handling overflow projects, have a big project with a hard deadline or just need to plug a gap left by staff departures, we have a large team ready to step in and help you stay on track.
I’m ready to help
 |
Scott Bourbeau Managing Director of Strategic Partnerships Call/Text: 419-376-2888 (US) Email: sbourbeau@namsa.com
|
NOTE: This page is only accessible to Terumo employees.